Enveric Biosciences Inc (NQ: ENVB )
0.5361
-0.0453
(-7.79%)
Streaming Delayed Price
Updated: 10:07 AM EDT, Jul 31, 2024
Add to My Watchlist
All News about Enveric Biosciences Inc
![](https://cdn.benzinga.com/files/images/story/2024/07/30/Headquarters-Rahway-Site-Entrance-HI_0.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/05/nktx_cancerresearch1600-1024x576.png)
![](https://investorplace.com/wp-content/uploads/2024/07/ekso1600.png)
![](https://investorplace.com/wp-content/uploads/2024/02/envb1600.png)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-federal-hall.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/07/30/xrdDAFgpVtycPU2-j3089375048-t23042013.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/07/25/Enveric-drug-for-mental-health-disorders.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20240725903859/en/2196252/22/Enveric.jpg)
![](https://mms.businesswire.com/media/20240715938433/en/2185676/22/Enveric.jpg)
![](/next-assets/images/schema-image-default.png)
![](https://mms.businesswire.com/media/20240710300771/en/2181789/22/Enveric.jpg)
From Enveric Biosciences
Via Business Wire
![](https://mms.businesswire.com/media/20240625428098/en/2168894/22/Enveric.jpg)
![](https://mms.businesswire.com/media/20240529455789/en/2145271/22/Enveric_logo.jpg)
![](https://investorplace.com/wp-content/uploads/2024/02/envb1600.png)
![](https://cdn.benzinga.com/files/images/story/2024/05/16/finance-and-psychedelics-anaterate--serg.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://mms.businesswire.com/media/20240514374351/en/2131630/22/Enveric_logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/05/14/Magic-Mushrooms-In-Laboratory--Psilocybi.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20240514809396/en/2129050/22/Enveric.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/05/08/cancer--reseracher--scientist--science--.jpeg?width=1200&height=800&fit=crop)
Cannabinoids With Chemotherapy For Breast Cancer: Psychedelics Biotech Inks $61M License Deal For Patented Methods
May 08, 2024
Via Benzinga
Topics
Cannabis
Exposures
Cannabis
![](https://mms.businesswire.com/media/20240508099100/en/2123993/22/Enveric.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/04/17/Psyched.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/04/03/ulta_beauty_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2024/02/envb1600.png)
![](https://cdn.benzinga.com/files/images/story/2024/Psyched_3.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/financial-psychedelics-Raimundo79-and-Bl.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20240326297550/en/2080198/22/Enveric_logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/Psyched_2.png?width=1200&height=800&fit=crop)
Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And More
March 20, 2024
Via Benzinga
Topics
Economy
Exposures
Interest Rates
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.